{"entity":{"id":"cartx-therapeutics","kind":"company","name":"CARTx Therapeutics","aka":[],"tldr":"CARTx Therapeutics, spun out of Nationwide Children's Hospital, is developing affordable off-the-shelf CAR gamma-delta T cell therapies from healthy donors for solid tumours and blood cancers.","summary":"CARTx Therapeutics uses polyclonal gamma-delta T cells from healthy donors, engineered with chimeric antigen receptors, to make allogeneic cell therapies that do not need to be manufactured from each patient, aiming at lower cost and faster access for solid tumours and blood cancers.","asOf":"2026-09-11","links":[{"label":"Official website","url":"https://www.cartx.health/"},{"label":"Listed on Future of Cancer Care Today (Sijbrandij Foundation)","url":"https://sijbrandijfoundation.org/fcct"}],"tags":["ctgov-sponsor","fcct-directory"],"related":[],"cancers":[],"sections":[],"technologies":["car-t","gamma-delta-t-cell-therapy"],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"notes":[],"provenance":{"editedBy":"OnCo ingestion (ClinicalTrials.gov v2 + sponsor websites)","editedOn":"2026-09-11"},"hq":"United States (city not published)","country":"US","companyType":"cell-therapy","website":"https://www.cartx.health/","stage":"startup","investors":[],"funding":[]},"route":"/companies/cartx-therapeutics/","neighbours":{"technology":[{"id":"car-t","kind":"technology","name":"CAR-T cell therapy","route":"/technologies/car-t/"},{"id":"gamma-delta-t-cell-therapy","kind":"technology","name":"Gamma-delta T cell therapy","route":"/technologies/gamma-delta-t-cell-therapy/"}]}}